Terms: = Uterine cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616
69 results:
1. ARID1 and brg1 Expression in Endometrial cancer.
Kontomanolis EN; Symeonidis P; Nikolettos K; Perros P; Rody A; Tsikouras P; Nikolettos N; Giatromanolaki A
In Vivo; 2024; 38(3):1260-1265. PubMed ID: 38688602
[TBL] [Abstract] [Full Text] [Related]
2. Cervical lymphoepithelioma-like carcinoma with deficient mismatch repair and loss of smarca4/brg1: a case report and five related cases.
Miyama Y; Kato T; Sato M; Yabuno A; Hasegawa K; Yasuda M
Diagn Pathol; 2024 Jan; 19(1):6. PubMed ID: 38178127
[TBL] [Abstract] [Full Text] [Related]
3. Divergent Malignant Melanocytic Differentiation in Ovarian Endometrioid Adenocarcinoma With Aberrant β-Catenin Expression: A Case Expanding the Histologic Spectrum of β-Catenin Activated Gynecologic Neoplasia.
Xu J; Weisman PS
Int J Gynecol Pathol; 2024 May; 43(3):302-307. PubMed ID: 37922945
[TBL] [Abstract] [Full Text] [Related]
4. Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation.
Tessier-Cloutier B; Kommoss FKF; Kolin DL; Němejcová K; Smith D; Pors J; Stewart CJR; McCluggage WG; Foulkes WD; von Deimling A; Köbel M; Lee CH
Mod Pathol; 2024 Jan; 37(1):100374. PubMed ID: 37925057
[TBL] [Abstract] [Full Text] [Related]
5. [Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours].
Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Le Frere Belda MA; Averous G; Leroux A; Bataillon G; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
Bull Cancer; 2024 Jan; 111(1):97-116. PubMed ID: 37806863
[TBL] [Abstract] [Full Text] [Related]
6. H3K27me3 deficiency in dedifferentiated carcinoma and carcinosarcoma of the endometrium.
Kihara A; Amano Y; Fukushima N; Fujiwara H; Niki T
Virchows Arch; 2023 Dec; 483(6):885-890. PubMed ID: 37770766
[TBL] [Abstract] [Full Text] [Related]
7. Establishment and validation of preclinical models of smarca4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.
Wong NKY; Llaurado Fernandez M; Kommoss FKF; Praveen Kumar P; Kim H; Liu J; Zhang G; Coatham M; Lin YY; Haegert AM; Volik S; Le Bihan S; Collins CC; Fu Y; Postovit LM; von Deimling A; Wu R; Xue H; Wang Y; Köbel M; Carey MS; Lee CH
Gynecol Oncol; 2023 Sep; 176():162-172. PubMed ID: 37556934
[TBL] [Abstract] [Full Text] [Related]
8. Genomic profiling of dedifferentiated endometrial carcinomas arising in the background of high-grade carcinoma: a targeted next-generation sequencing study.
Olkhov-Mitsel E; Busca A; Parra-Herran C; Amemiya Y; Nofech-Mozes S; Djordjevic B; Nucci MR; Seth A; Mirkovic J
Histopathology; 2023 Sep; 83(3):366-375. PubMed ID: 37222195
[TBL] [Abstract] [Full Text] [Related]
9. Pathological characteristics and immune microenvironment of smarca4-deficient undifferentiated uterine sarcoma.
Gao J; Fan R; Chen D; Hou J; Chen H; Lu M
Diagn Pathol; 2023 May; 18(1):62. PubMed ID: 37194064
[TBL] [Abstract] [Full Text] [Related]
10. Landscape of chromatin remodeling gene alterations in endometrial carcinoma.
Momeni-Boroujeni A; Vanderbilt C; Yousefi E; Abu-Rustum NR; Aghajanian C; Soslow RA; Ellenson LH; Weigelt B; Murali R
Gynecol Oncol; 2023 May; 172():54-64. PubMed ID: 36958196
[TBL] [Abstract] [Full Text] [Related]
11. ARID1A Regulates Progesterone Receptor Expression in Early Endometrial Endometrioid Carcinoma Pathogenesis.
Asaka S; Liu Y; Yu ZC; Rahmanto YS; Ono M; Asaka R; Miyamoto T; Yen TT; Ayhan A; Wang TL; Shih IM
Mod Pathol; 2023 Feb; 36(2):100045. PubMed ID: 36853791
[TBL] [Abstract] [Full Text] [Related]
12. Germline pathogenic
Witkowski L; Nichols KE; Jongmans M; van Engelen N; de Krijger RR; Herrera-Mullar J; Tytgat L; Bahrami A; Mar Fan H; Davidson AL; Robertson T; Anderson M; Hasselblatt M; Plon SE; Foulkes WD
J Med Genet; 2023 Oct; 60(10):987-992. PubMed ID: 36813544
[TBL] [Abstract] [Full Text] [Related]
13. ARID1A, brg1, and INI1 deficiency in undifferentiated and dedifferentiated endometrial carcinoma: a clinicopathologic, immunohistochemical, and next-generation sequencing analysis of a case series from a single institution.
Korentzelos D; Elishaev E; Zhao C; Jones MW; Soong TR; Lesnock J; Orellana T; Zeccola A; Diamantopoulos LN; Wald AI; Bhargava R
Hum Pathol; 2022 Dec; 130():65-78. PubMed ID: 36252860
[TBL] [Abstract] [Full Text] [Related]
14. uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
[TBL] [Abstract] [Full Text] [Related]
15. Update on Mesenchymal Lesions of the Lower Female Genital Tract.
Croce S; Perret R; Le Loarer F
Surg Pathol Clin; 2022 Jun; 15(2):341-367. PubMed ID: 35715165
[TBL] [Abstract] [Full Text] [Related]
16.
Nakra T; Kakkar A; Mathur SR; Jain D; Kumar S
Int J Surg Pathol; 2023 Feb; 31(1):104-109. PubMed ID: 35466749
[No Abstract] [Full Text] [Related]
17. Endometrial neuroendocrine carcinoma and undifferentiated carcinoma are distinct entities with overlap in neuroendocrine marker expression.
Tessier-Cloutier B; Kang EY; Alex D; Stewart CJR; McCluggage WG; Köbel M; Lee CH
Histopathology; 2022 Jul; 81(1):44-54. PubMed ID: 35394077
[TBL] [Abstract] [Full Text] [Related]
18. The value of SOX2 in the differential diagnosis of smarca4 (brg1)-deficient uterine neoplasms.
Zheng L; Zhang L; Wang XI; Katz G; Tandon N; Zhao B; Lucci J; Ding J; Zhang S
Hum Pathol; 2022 Jun; 124():45-55. PubMed ID: 35331811
[TBL] [Abstract] [Full Text] [Related]
19. Cellular context determines DNA methylation profiles in SWI/SNF-deficient cancers of the gynecologic tract.
Kommoss FK; Tessier-Cloutier B; Witkowski L; Forgo E; Koelsche C; Köbel M; Foulkes WD; Lee CH; Kolin DL; von Deimling A; Howitt BE
J Pathol; 2022 Jun; 257(2):140-145. PubMed ID: 35218556
[TBL] [Abstract] [Full Text] [Related]
20. smarca4-Deficient Carcinoma of uterine Cervix Resembling SCCOHT-Case Report.
Sirák I; Laco J; Vošmiková H; Mell LK; Herrera FG; Šenkeříková M; Vošmik M
Pathol Oncol Res; 2021; 27():1610003. PubMed ID: 34970085
[TBL] [Abstract] [Full Text] [Related]
[Next]
